Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis
Патологически подтвержденный спектр врастания плаценты без предлежания плаценты: систематический обзор и метаанализ
2023-05-19
SCID: 54.1/j2xyxjby
Discuss with AI
assisted reproductive technologyplacenta accreta spectrumplacenta previaprevious uterine proceduressystematic review and meta-analysis
Figures from the paper
Abstract (AI)
OBJECTIVE: This systematic review and meta-analysis aimed to assess clinical characteristics related to pathologically proven placenta accreta spectrum without placenta previa. DATA SOURCES: A literature search of PubMed, the Cochrane database, and Web of Science was performed from inception to September 7, 2022. STUDY ELIGIBILITY CRITERIA: The primary outcomes were invasive placenta (including increta or percreta), blood loss, hysterectomy, and antenatal diagnosis. In addition, maternal age, assisted reproductive technology, previous cesarean delivery, and previous uterine procedures were investigated as potential risk factors. The inclusion criteria were studies evaluating the clinical presentation of pathologically diagnosed PAS without placenta previa. METHODS: statistics were calculated for each study outcome for each group. The main analysis was a random-effects analysis. RESULTS: Among 2598 studies that were initially retrieved, 5 were included in the review. With the exception of 1 study, 4 studies were included in the meta-analysis. This meta-analysis showed that placenta accreta spectrum without placenta previa was associated with less risk of invasive placenta (odds ratio, 0.24; 95% confidence interval, 0.16-0.37), blood loss (mean difference, -1.19; 95% confidence interval, -2.09 to -0.28) and hysterectomy (odds ratio, 0.11; 95% confidence interval, 0.02-0.53), and more difficult to diagnose prenatally (odds ratio, 0.13; 95% confidence interval, 0.04-0.45) than placenta accreta spectrum with placenta previa. In addition, assisted reproductive technology and a previous uterine procedure were strong risk factors for placenta accreta spectrum without placenta previa, whhereas previous cesarean delivery was a strong risk factor for placenta accreta spectrum with placenta previa. CONCLUSION: The differences in clinical aspects of placenta accreta spectrum with and without placenta previa need to be understood.
Key Findings
1
Assisted reproductive technology and previous uterine procedures were strong risk factors for placenta accreta spectrum without placenta previa, whereas previous cesarean delivery was a strong risk factor when placenta previa was present.
2
Cases without placenta previa had lower blood loss than cases with placenta previa (mean difference −1.19; 95% CI, −2.09 to −0.28).
3
Placenta accreta spectrum without placenta previa was associated with lower odds of invasive placenta than cases with placenta previa (OR 0.24; 95% CI, 0.16–0.37).
4
Placenta accreta spectrum without placenta previa was associated with substantially lower odds of hysterectomy (OR 0.11; 95% CI, 0.02–0.53).
5
Prenatal diagnosis was more difficult without placenta previa, with lower odds of antenatal detection (OR 0.13; 95% CI, 0.04–0.45).
Research Object
Pathologically diagnosed placenta accreta spectrum without placenta previa
Research Subject
Clinical characteristics, outcomes, prenatal diagnosability, and risk factors compared with placenta accreta spectrum with placenta previa
Publication Details
Publication Date
2023-05-19
Journal
Publisher
ISSN
Cited by
32
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest